This is a preview of subscription content, access via your institution.



Literatur
1.1. Leitlinienreport
Mayer G, Fietze I, Fischer J, Penzel T, Riemann D, Rodenbeck A, Sitter H, Teschler H (2009) S3-Leitlinie Nicht-erholsamer Schlaf/Schlafstörungen. Somnologie (Berl) 13:1–160
2.1. Ätiologie und Pathophysiologie
Baglioni C, Spiegelhalder K, Lombardo C, Riemann D (2010) Sleep and emotions: a focus on insomnia. Sleep Med Rev 14:227–238
Bonnet MH, Arand DL (2010) Hyperarousal and insomnia: state of the science. Sleep Med Rev 14:9–15
Deutsche Gesellschaft für Arbeitsmedizin und Umweltmedizin (2006). Leitlinie Schicht- und Nachtarbeit. http://www.asu-arbeitsmedizin.com/ASU-2006-8/Arbeitsmedizinische-Leitlinie-der-Deutschen-Gesellschaft-fuer-Arbeitsmedizin-und-Umweltmedizin-e-V-BRNacht-und-Schichtarbeit,QUlEPTIwMTE1NCZNSUQ9MTEwNTc2.html
Ellis JG, Gherman P, Espie CA, Riemann D, Perlis ML (2012) Acute insomnia: current conceptualizations and future directions. Sleep Med Rev 16:5–14
Espie CA, Broomfield NM, MacMahon KM, Macphee LM, Taylor LM (2006) The attention-intention-effort pathway in the development of psychophysiologic insomnia: a theoretical review. Sleep Med Rev 10:215–245
Feige B, Baglioni C, Spiegelhalder K, Hirscher V, Nissen C, Riemann D (2013) The microstructure of sleep in primary insomnia: an overview and extension. Int J Psychophysiol 89:171–180
Harvey AG (2002) A cognitive model of insomnia. Behav Res Ther 40:869–893
Levenson JC, Kay DB, Buysse DJ (2015) The pathophysiology of insomnia. Chest 147:1179–1192
Morin CM, Benca R (2012) Chronic insomnia. Lancet 379:1129–1141
Morin CM, Drake CL, Harvey AG, Krystal AD, Manber R, Riemann D, Spiegelhalder K (2015) Insomnia disorder. Nat Rev Dis Primers 1:15026. doi:10.1038/nrdp.2015.26
Palagini L, Biber K, Riemann D (2014) The genetics of insomnia – evidence for epigenetic mechanisms? Sleep Med Rev 18(3):225–235. doi:10.1016/j.smrv.2013.05.002
Perlis ML, Giles DE, Mendelson WB, Bootzin RR, Wyatt JK (1997) Psychophysiological insomnia: the behavioural model and a neurocognitive perspective. J Sleep Res 6:179–188
Riemann D, Spiegelhalder K, Feige B, Voderholzer U, Berger M, Perlis M, Nissen C (2010) The hyperarousal model of insomnia: a review of the concept and its evidence. Sleep Med Rev 14:19–31
Riemann D, Spiegelhalder K, Nissen C, Hirscher V, Baglioni C, Feige B (2012) REM sleep instability – a new pathway for insomnia? Pharmacopsychiatry 45:167–176
Riemann D, Spiegelhalder K, Espie C, Pollmächer T, Léger D, Bassetti C, van Someren E (2011) Chronic insomnia: clinical and research challenges – an agenda. Pharmacopsychiatry 44:1–14
Riemann D, Nissen C, Palagini L, Otte A, Perlis ML, Spiegelhalder K (2015) The neurobiology, investigation, and treatment of chronic insomnia. Lancet Neurol 14:547–558
Saper CB, Scammell TE, Lu J (2005) Hypothalamic regulation of sleep a‑nd circadian rhythms. Nature 437:1257–1263
Sateia MJ, Nowell PD (2004) Insomnia. Lancet 364:1959–1973
Silber MH (2005) Chronic insomnia. New Engl J Med 353:803–810
Spielman AJ, Caruso LS, Glovinsky PA (1987) A behavioral perspective on insomnia treatment. Psychiatr Clin North Am 10:541–553
Winkelman JW (2015) Insomnia disorder. N Engl J Med 373:1437–1444
2.2. Begriffsbestimmung und diagnostische Klassifikationssysteme
American Psychiatric Association (Hrsg) (2013) DSM 5 (diagnostic and statistical manual of mental disorders). American Psychiatric Association, Washington DC
WHO (1992) Kapitel V–F 51.0 Insomnien. In: ICD-10 (international statistical classification of diseases and related health problems). WHO, Genf
American Academy of Sleep Medicine (Hrsg) (2014) ICSD-3 (International Classification of Sleep ICSD-2 Disorders). American Association of Sleep Medicine, Darien
National Institutes of Health (2005) National Institutes of Health state of the science conference statement: manifestations and management of chronic insomnia in adults June 13–15, 2005. Sleep 28:1049–1057
2.3. Diagnostik und Differentialdiagnostik
Baglioni C, Regen W, Teghen A, Spiegelhalder K, Feige B, Nissen C, Riemann D (2014) Sleep changes in the disorder of insomnia: a meta-analysis of polysomnographic studies. Sleep Med Rev 18:195–213
Bastien CH, Vallières A, Morin CM (2001) Validation of the insomnia severity index as an outcome measure for insomnia research. Sleep Med 2:297–307
Benca RM, Obermeyer WH, Thisted RA, Gillin JC (1992) Sleep and psychiatric disorders. A meta-analysis. Arch Gen Psychiatry 49:651–668
Buysse DJ, Reynolds CF, Monk TH et al (1989) The pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193–213
Carney CE, Buysse DJ, Ancoli-Israel S, Edinger JD, Krystal AD, Lichstein K, Morin CM (2012) The consensus sleep diary: standardizing prospective sleep self-monitoring. Sleep 35:287–302
Crönlein T, Geisler P, Langguth B, Eichhammer P, Jara C, Pieh C, Zulley J, Hajak G (2012) Polysomnography reveals unexpectedly high rates of organic sleep disorders in patients with prediagnosed primary insomnia. Sleep Breath 16:1097–1103
Feige B, Al-Shajlawi A, Nissen C, Voderholzer U, Hornyak M, Spiegelhalder K, Kloepfer C, Perlis M, Riemann D (2008) Does REM sleep contribute to subjective wake time in primary insomnia? A comparison of polysomnographic and subjective sleep in 100 patients. J Sleep Res 17:180–190
Görtelmeyer R (2005) Schlaffragebogen A und B. In: CIPS: Internationale Skalen für Psychiatrie, 5. Aufl. Beltz PVU, Weinheim, S 537–370
Hoffmann RM, Müller T, Hajak G, Cassel W (1997) Abend-Morgenprotokolle in Schlafforschung und Schlafmedizin – Ein Standardinstrument für den deutschsprachigen Raum. Somnologie (Berl) 1:103–109
Kolla BP, Mansukhani S, Mansukhani MP (2016) Consumer sleep tracking devices: a review of mechanisms, validity and utility. Expert Rev Med Devices 13(5):497–506. doi:10.1586/17434440.2016.1171708
Liendl S, Hoffmann RM (1999) Compliance-Probleme bei der Bearbeitung von Abend-Morgen-Protokollen – Entwicklung einer Kurzversion der Standardprotokolle der DGSM. Somnologie (Berl) 3:73–77
Morgenthaler T, Alessi C, Friedman L, Owens J, Kapur V, Boehlecke B, Brown T, Chesson A Jr, Coleman J, Lee-Chiong T, Pancer J, Swick TJ (2007) Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: an update for 2007. Sleep 30:519–529
Ohayon MM, Roth T (2013) Place of chronic insomnia in the course of depressive and anxiety disorders. J Psychiatr Res 37:9–15
Shahid A, Wilkinson K, Marcu S, Shapiro CM (Hrsg) (2012) STOP, THAT and one hundred other sleep scales. Springer, New York
2.4. Epidemiologie – Risikofaktoren
Morin CM, Bélanger L, LeBlanc M, Ivers H, Savard J, Espie CA, Mérette C, Baillargeon L, Grégoire J‑P (2009) The natural history of insomnia. Arch Intern Med 169:447–453
Ohayon MM (2002) Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 6:97–111
Schlack R, Hapke U, Maske U, Busch MA, Cohrs S (2013) Häufigkeit und Verteilung von Schlafproblemen und Insomnie in der deutschen Erwachsenenbevölkerung. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 5(6):740–748
Thun E, Bjorvatn B, Akerstedt T, Moen BE, Waage S, Molde H, Pallesen S (2016) Trajectories of sleepiness and insomnia symptoms in Norwegian nurses with and without night work and rotational work. Chronobiol Int 33:480–489
2.5. Gesundheitsrisiken
Anothaisintawee T, Reutrakul S, Van Cauter E, Thakkinstian A (2015) Sleep disturbances compared to traditional risk factors for diabetes development: systematic review and meta-analysis. Sleep Med Rev 30:11–24
Baglioni C, Battagliese G, Feige B, Spiegelhalder K, Nissen C, Voderholzer U, Lombardo C, Riemann D (2011) Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. J Affect Disord 135:10–19
Bernert RA, Turvey CL, Conwell Y, Joiner TE (2014) Association of poor subjective sleep quality with risk for death by suicide during a 10-year period – a longitudinal, population-based study of late life. JAMA Psychiatry 71:1129–1137
Bjørngaard JH, Bjerkeset O, Romundstad P, Gunnell D (2011) Sleeping problems and suicide in 75,000 Norwegian adults: a 20 year follow-up of the HUNT I study. Sleep 34:1155–1159
Chen X, Beydoun MA, Wang Y (2008) Is sleep duration associated with childhood obesity? A systematic review and meta-analysis. Obesity (Silver Spring) 16:265–274
Crönlein T, Langguth B, Busch V, Rupprecht R, Wetter TC (2015) Severe chronic insomnia is not associated with higher body mass index. J Sleep Res 24:514–517
Laugsand LE, Vatten LJ, Platou C, Janszky I (2011) Insomnia and the risk of acute myocardial infarction: a population study. Circulation 124:2073–2081
Laugsand LE, Strand LB, Platou C, Vatten LJ, Janszky I (2014a) Insomnia and the risk of incident heart failure: A population study. Eur Heart J 35:1382–1393
Laugsand LE, Strand LB, Vatten LJ, Janszky I, Bjørngaard JH (2014b) Insomnia symptoms and risk for unintentional fatal injuries – The HUNT Study. Sleep 37:1777–1786
Li M, Zhang X‑W, Hou W‑S, Tang Z‑Y (2014) Insomnia and risk of cardiovascular disease: a meta-analysis of cohort studies. Int J Cardiol 176:1044–1047
Malik S, Kanwar A, Sim LA, Prokop LJ, Wang Z, Benkhadra K (2014) The association between sleep disturbances and suicidal behaviors in patients with psychiatric diagnoses: a systematic review and meta-analysis. Syst Rev 3:1–9
Mayer G, Jennum P, Riemann D, Cauvilliers Y (2011) Insomnia in central neurologic diseases – occurrence and management. Sleep Med Rev 15:369–378
Meng L, Zheng Y, Hui R (2013) The relationship of sleep duration and insomnia to risk of hypertension incidence: a meta-analysis of prospective cohort studies. Hypertens Res 36:985–995
Neckelmann D, Mykletun A, Dahl AA (2007) Chronic insomnia as a risk factor for developing anxiety and depression. Sleep 30:873–880
Palagini L, Bruno RM, Gemignani A, Baglioni C, Ghiadoni L, Riemann D (2013) Sleep loss and hypertension: a systematic review. Curr Pharm Des 19:2409–2419
Patel SR, Hu FB (2008) Short sleep duration and weight gain: a systematic review. Obesity (Silver Spring) 16:643–653
Riemann D, Voderholzer U (2003) Primary insomnia: a risk factor to develop depression? J Affect Disord 76:255–259
Pigeon WR, Pinquart M, Conner K (2012) Meta-analysis of sleep disturbance and suicidal thoughts and behaviors. J Clin Psychiatry 73:1160–1167
Sexton CE, Storsve AB, Walhovd KB et al (2014) Poor sleep quality is associated with increased cortical atrophy in community-dwelling adults. Neurology 83:967–973
Sivertsen B, Øverland S, Pallesen S, Bjorvatn B, Nordnus IH, MÆland JG, Mykletun A (2009a) Insomnia and long sleep duration are risk factors for later work disability. The Hordaland Health Study. J Sleep Res 18:122–128
Sivertsen B, Øverland S, Bjorvatn B, MÆland JG, Mykletun A (2009b) Does insomnia predict sick leave? The Hordaland Health Study. J Psychosom Res 66:67–74
Sofi F, Cesari F, Casini A, Macchi C, Abbate R, Gensini GF (2014) Insomnia and risk of cardiovascular disease: a meta-analysis. Eur J Prev Cardiol 21:57–64
Weissman MM, Greenwald S, Niño-Murcia G, Dement WC (1997) The morbidity of insomnia uncomplicated by psychiatric disorders. Gen Hosp Psychiatry 19:245–250
Yaffe K, Falvey CM, Hoang T (2014) Connections between sleep and cognition in older adults. Lancet Neurol 13:1017–1028
2.6. Kosten
Collins PY, Patel V, Joestl SS (2011) Grand challenges in global mental health. Nature 475:27–30
Daley M, Morin CM, LeBlanc M, Grégoire J‑P, Savard J (2009) The economic burden of insomnia: direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms and good sleepers. Sleep 32:55–64
Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E, Dodel R, Ekman M, Faravelli C, Fratiglioni L, Gannon B, Jones DH, Jennum P, Jordanova A, Jönsson L, Karampampa K, Knapp M, Kobelt G, Kurth T, Lieb R, Linde M, Ljungcrantz C, Maercker A, Melin B, Moscarelli M, Musayev A, Norwood F, Preisig M, Pugliatti M, Rehm J, Salvador-Carulla L, Schlehofer B, Simon R, Steinhausen H‑C, Stovner LJ, Vallat J‑M, Van den Bergh P, van Os J, Vos P, Xu W, Wittchen H‑U, Jönsson B, Olesen J (2011) Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 21:718–779
Léger D, Bayon V (2010) Societal costs of insomnia. Sleep Med Rev 14:379–389
Ozminkowski RJ, Wang S, Walsh JK (2007) The direct and indirect costs of untreated insomnia in adults in the United States. Sleep 30:263–273
2.7.1. Kognitive Verhaltenstherapie
Backhaus J, Hohagen F, Voderholzer U, Riemann D (2001) Long-term effectiveness of a short-term cognitive-behavioral group treatment for primary insomnia. Eur Arch Psychiatry Clin Neurosci 251:35–41
Belleville G, Cousineau H, Levrier K, St. Pierre-Delorme ME (2011) Meta-analytic review of the impact of cognitive-behaviour therapy for insomnia on concomitant anxiety. Clin Psychol Rev 31:638–652
Borbély AA (1982) A two process model of sleep regulation. Hum Neurobiol 1:195–204
Borbély AA, Achermann P (1999) Sleep homeostasis and models of sleep regulation. J Biol Rhythms 14:557–568
Buysse DJ, Germain A, Moul DE, Franzen PL, Brar LK, Fletcher ME, Begley A, Houck PR, Mazumdar S, Reynolds CF, Monk TH (2011) Efficacy of brief behavioral treatment for chronic insomnia in older adults. Arch Intern Med 171:887–895
Cheng SK, Dizon J (2012) Computerised cognitive behavioural therapy for insomnia: a systematic review and meta-analysis. Psychother Psychosom 81:206–216
Christensen H, Batterham PJ, Gosling JA, Ritterband LM, Griffiths KM, Thorndike FP, Glozier N, O’Dea B, Hickie IB, Mackinnon AJ (2016) Effectiveness of an online insomnia program (SHUTi) for prevention of depressive episodes (the GoodNight Study): a randomised controlled trial. Lancet Psychiatry 3(4):333–341. doi:10.1016/S2215-0366(15)00536-2
Crönlein T (2013) Primäre Insomnie – Ein Gruppentherapieprogramm für den stationären Bereich. Hogrefe, Göttingen
Crönlein T, Langguth B, Geisler P, Wetter TC, Eichhammer P (2014) Fourteen-day inpatient cognitive-behavioural therapy for insomnia: a logical and useful extension of the stepped-care approach for the treatment of insomnia. Psychother Psychosom 83:255–256
Ellis JG, Cushing T, Germain A (2015) Treating acute insomnia: a randomized controlled trial of a „single-shot“ of cognitive behavioral therapy for insomnia. Sleep 38:971–978
Espie CA, MacMahon KMA, Kelly H‑L, Broomfield NM, Douglas NJ, Engleman HM, McKinstry B, Morin CM, Walker A, Wilson P (2007) Randomized clinical effectiveness trial of nurse-administered small-group cognitive behavior therapy for persistent insomnia in general practice. Sleep 30:574–584
Espie CA, Kyle SD, Williams C, Ong JC, Douglas NJ, Hames P, Brown JSL (2012) A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep 35:769–781
Geiger-Brown JM, Rogers VE, Liu W, Ludeman EM, Downton KD, Diaz-Abad M (2015) Cognitive behavioral therapy in persons with comorbid insomnia: a meta-analysis. Sleep Med Rev 23:54–67
Gosling JA, Glozier N, Griffiths K, Ritterband L, Thorndike F, Mackinnon A, Hehir KK, Bennett A, Bennett K, Christensen H (2014) The GoodNight study – online CBT for insomnia for the indicated prevention of depression: study protocol for a randomized controlled trial. Trials 15:56. doi:10.1186/1745-6215-15-56
Hauri PJ (1991) Case studies in insomnia. Plenum Medical Book Company, New York
Hertenstein E, Spiegelhalder K, Johann A, Riemann D (2015) Prävention und Psychotherapie der Insomnie. Kohlhammer, Stuttgart
Ho FY, Chan CS, Tang KN (2016) Cognitive-behavioral therapy for sleep disturbances in treating posttraumatic stress disorder symptoms: a meta-analysis of randomized controlled trials. Clin Psychol Rev 43:90–102. doi:10.1016/j.cpr.2015.09.005
Ho FY, Chung K‑F, Yeung W‑F, Ng TH, Kwan K‑S, Yung K‑P, Cheng SK (2015) Self-help cognitive-behavioral therapy for insomnia: a meta-analysis of randomized controlled trials. Sleep Med Rev 19:17–28
Irwin MR, Cole JC, Nicassio PM (2006) Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in middle-aged adults an in older adults 55+ years of age. Health Psychol 25:3–14
Irish LA, Kline CE, Gunn HE, Buysse DJ, Hall MH (2015) The role of sleep hygiene in promoting public health: a review of empirical evidence. Sleep Med Rev 22:2–36
Järnefelt H, Lagerstedt R, Kajaste S, Sallinen M, Savolainen A, Hublin C (2012) Cognitive behavioral therapy for shift workers with chronic insomnia. Sleep Med 13:1238–1246
Johnson JA, Rash JA, Campbell TS, Savard J, Gehrman PR, Perlis M, Carlson LE, Garland SN (2016) A systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy for insomnia (CBT-I) in cancer survivors. Sleep Med Rev 27:20–28
Koffel EA, Koffel JB, Gehrman PR (2015) A meta-analysis of group cognitive behavioral therapy for insomnia. Sleep Med Rev 19:6–16
Lacks P, Rotert M (1986) Knowledge and practice of sleep hygiene techniques in insomniacs and good sleepers. Behav Res Ther 24:365–368
Miller CB, Espie CA, Epstein DR, Friedman L, Morin CM, Pigeon WR, Spielman AJ, Kyle SD (2014) The evidence base of sleep restriction therapy for treating insomnia disorder. Sleep Med Rev 18(5):415–424. doi:10.1016/j.smrv.2014.01.006
Mitchell MD, Gehrman P, Perlis ML, Umscheid CA (2012) Comparative effectiveness of cognitive behavioral therapy for insomnia: a systematic reveiw. BMC Fam Pract 13(40):1–11
Montgomery P, Dennis J (2004) A systematic review of non-pharmacological therapies for sleep problems in later life. Sleep Med Rev 8:47–62
Morgenthaler T, Kramer M, Alessi C, Friedman L, Boehlecke B, Brown T, Coleman J, Kapur V, Lee-Chiong T, Owens J, Pancer J, Swick T (2006) Practice parameters for the psychological and behavioral treatment of insomnia: an update. An American Academy of Sleep medicine report. Sleep 29:1415–1419
Morin CM, Culbert JP, Schwartz SM (1994) Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy. Am J Psychiatry 151:1172–1180
Morin CM, Colecchi C, Stone J, Sood R, Brink D (1999) Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA 281:991–999
Morin CM, Vallières A, Guay B, Ivers H, Savard J, Mérette C, Bastien C, Baillargeon L (2009) Cognitive behanvioral therapy, singly and combined with medication, for persistent insomnia. JAMA 301:2005–2015
Müller T, Paterok B (1999) Schlaftraining – Ein Therapiemanual zur Behandlung von Schlafstörungen. Hogrefe, Göttingen
Murtagh DRR, Greenwood KM (1995) Identifying effective psychological treatments for insomnia: a meta-analysis. J Consult Clin Psychol 63:79–89
Okajima I, Komada Y, Inoue Y (2011) A meta-analysis on the treatment effectiveness of cognitive behavioral therapy for primary insomnia. Sleep Biol Rhythms 9:24–34
Pallesen S, Nordhus IH, Kvale G (1998) Nonpharmacological interventions for insomnia in older adults: a meta-analysisn of treatment efficacy. Psychotherapy (Chic) 35:472
Riemann D (2016) Ratgeber Schlafstörungen - Informationen für Betroffene und Angehörige, 2. Aufl. Hogrefe, Göttingen
Riemann D, Perlis ML (2009) The treatments of chronic insomnia: a review of benzo-diazepine receptor agonists and psychological and behavioral therapies. Sleep Med Rev 13:205–214
Ritterband LM, Thorndike FP, Gonder-Frederick LA, Magee JC, Bailey ET, Saylor DK, Morin CM (2009) Efficacy of an internet-based behavioral intervention for adults with insomnia. Arch Gen Psychiatry 66:692–698
Smith MT, Perlis ML, Park A, Smith MS, Pennington J, Giles DE, Buysse DJ (2002) Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry 159:5–11
Spiegelhalder K, Backhaus J, Riemann D (2011) Schlafstörungen – Fortschritte der Psychotherapie. Hogrefe, Göttingen
Stiftung Warentest (2016) Endlich schlafen. Stiftung Warentest, Berlin
Tang NKY, Lereya ST, Boulton H, Miller MA, Wolke D, Cappuccio FP (2015) Nonpharmacological treatments of insomnia for long-term painful conditions: a systematic review and meta-analysis of patient-reported outcomes in randomized controlled trials. Sleep 38:1751–1764
Trauer JM, Qian MY, Doyle JS, Rajaratnam SMW (2015) Cognitive behavioral therapy for chronic insomnia. Ann Intern Med 163:191–204
Van Straten A, Cuijpers P (2009) Self-help therapy for insomnia: a meta-analysis. Sleep Med Rev 13:61–71
Wu JQ, Appleman ER, Salazar RD, Ong JC (2015) Cognitive behavioral therapy for insomnia comorbid with psychiatric and medical conditions. JAMA Intern Med 175(1461):1472
Ye Y, Zhang Y, Chen J, Liu J, Li X, Liu Y, Lang Y, Lin L, Yang X, Jiang X (2015) Internet-based cognitive behavioral therapy for insomnia (ICBT-I) improves comorbid anxiety and depression – a meta-analysis of randomized controlled trials. PLOS ONE 10:eO142258. doi:10.1371/journal.pone.0142258
Zachariae R, Lyby MS, Ritterband LM, O’Toole MS (2016) Efficacy of internet-delivered cognitive-behavioral therapy for insomnia – A systematic review and meta-analysis of randomized controlled trials. Sleep Med Rev 30:1–10. doi:10.1016/j.smrv.2015.10.004
2.7.2. Pharmakotherapie der Insomnie
Belanger L, Vallieres A, Ivers H, Moreau V, Lavigne G, Morin CM (2007) Meta-analysis of sleep changes in control groups of insomnia treatment trials. J Sleep Res 16:77–84
Hróbjartsson A, Gøtzsche PC (2001) Is the placebo powerless? N Engl J Med 344:1594–1602
Mattila T, Stoyanova V, Elferink A, Gispen-de Wied C, de Boer A, Wohlfarth T (2011) Insomnia medication: Do published studies reflect the complete picture of efficacy and safety? Eur Neuropsychopharmacol 21:500–5007
McCall WV, D’Agostino R, Dunn A (2003) A meta-analysis of sleep changes associated with placebo in hypnotic clinical trials. Sleep Med 4:57–62
Nissen C, Frase L, Hajak G, Wetter TC (2014) Hypnotika – Stand der Forschung. Nervenarzt 85:67–76
Riemann D, Riemann D, Nissen C (2012) Sleep and psychotropic drugs. In: Morin CM, Espie CA (Hrsg) Oxford handbook of sleep and sleep disorders. Oxford University Press, Oxford
Winkler A, Rief W (2015) Effect of placebo conditions on polysomnographic parameters in primary insomnia: a meta-analysis. Sleep 38:925–931
2.7.2.1. Benzodiazepine und Benzodiazepin-Rezeptor-Agonisten
Buscemi N, Vandermeer B, Friesen C, Bialy L, Tubman M, Ospina M, Klassen TP, Witmans M (2007) The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs. J Gen Intern Med 22(9):1335–1350. doi:10.1007/s11606-007-0251-z
Dündar Y, Dodd S, Strobl J, Boland A, Dickson R, Walley T (2004) Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis. Hum Psychopharmacol 19:305–322
Glass J, Lanctôt KL, Hermann N, Sproule BA, Busto UE (2005) Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. Br Med J 331:1–7
Holbrook AM, Crowther R, Lotter A, Cheng C, King D (2000) Meta-analysis of benzodiazepine use in the treatment of insomnia. Can Med Assoc J 162:225–233
Huedo-Medina T, Kirsch I, Klonizakis M, Siriwardena AN (2012) Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration. Br Med J 345:1–13
Nowell PD, Mazumdar S, Buysse DJ, Dew MA (1997) Benzodiazepines and zolpidem for chronic insomnia – a meta-analysis of treatment efficacy. JAMA 278:2170–2177
Winkler A, Auer C, Doering BK, Rief W (2014) Drug treatment of primary insomnia: a meta-analysis of polysomnographic randomized controlled trials. CNS Drugs 28:799–816
2.7.2.2. Sedierende Antidepressiva
Buscemi N, Vandermeer B, Friesen C, Bialy L, Tubman M, Ospina M, Klassen TP, Witmans M (2007) The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs. J Gen Intern Med 22(9):1335–1350. doi:10.1007/s11606-007-0251-z
McCleery J, Cohen DA, Sharpley AL (2014) Pharmacotherapies for sleep disturbances in Alzheimer’s disease (review). Cochrane Database Syst Rev. doi:10.1002/14651858.cd009178.pub2
Winkler A, Auer C, Doering BK, Rief W (2014) Drug treatment of primary insomnia: a meta-analysis of polysomnographic randomized controlled trials. CNS Drugs 28:799–816
Yeung W‑F, Chung K‑F, Yung K‑P, Ng T (2015) Doxepin for insomnia: a systematic review of randomized placebo-controlled trials. Sleep Med Rev 19:75–83
2.7.2.3. Neuroleptika
Anderson SL, Vande Griend JP (2014) Quetiapine for insomnia: a review of the literature. Am J Health Syst Pharm 71:394–402
Cohrs S (2008) Sleep disturbances in patients with schizophrenia. Impact and effects of antipsychotics. CNS Drugs 22:939–962
Monti JM, Monti D (2004) Sleep in schizophrenia patients and the effects of antipsychotic drugs. Sleep Med Rev 8:133–148
2.7.2.4. Antihistaminika
Vande Griend JP, Anderson SL (2003) Histamine-1 receptor antagonism for treatment of insomnia. J Am Pharm Assoc 52:210–219
2.7.2.5. Phytotherapeutika
Bent S, Padula A, Moore D, Patterson M, Mehling W (2006) Valerian for sleep: a systematic review and meta-analysis. Am J Med 119:1005–1012
Fernández-San-Martín MI, Masa-Font R, Palacios-Soler L, Sancho-Gómez P, Calbó-Caldentey C, Flores-Mateo G (2010) Effectiveness of valerian on insomnia: a meta-analysis of randomized placebo-controlled trials. Sleep Med 11:505–511
Leach MJ, Page AT (2015) Herbal medicine for insomnia: a systematic review and meta-analysis. Sleep Med Rev 24:1–12
Ni X, Shergis JL, Guo X, Zhang AL, Li Y, Lu C, Xue CC (2015) Updated clinical evidence of Chinese herbal medicine for insomnia: a systematic review and meta-analysis of randomized controlled trials. Sleep Med 16:1462–1481
2.7.2.6. Melatonin
Braam W, Smits MG, Didden R, Korzilius H, van Geijlswijk IM, Curfs LMG (2009) Exogenous melatonin for sleep problems in individuals with intellectual disability: a meta-analysis. Dev Med Child Neurol 51:340–348
Brzezinski A, Vangel MG, Wurtman RJ, Norrie G, Zhdanova I, Ben-Shushan A, Ford I (2005) Effects of exogenous melatonin on sleep: a meta-analysis. Sleep Med Rev 9:41–50
Buscemi N, Vandermeer B, Hootin N, Pandya R, Tjosvold L, Hartling L, Baker G, Klassen TP, Vohra S (2005) The efficacy and safety of exogenous melatonin for primary sleep disorders – a meta-analysis. J Gen Intern Med 20:1151–1158
Buscemi N, Vandermeer B, Hootin N, Pandya R, Tjosvold L, Hartling L, Vohra S, Klassen TP, Baker G (2006) Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis. Br Med J 332:385–393
European Medicines Agency (2015) Public summary of opinion on orphan designation: Tasimelteon for the treatment of non-24-hour sleep-wake disorder in blind people with no light perception. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/orphans/2011/03/human_orphan_000903.jsp&mid=WC0b01ac058001d12b. Zugegriffen: 31.01.2016
Ferracioli-Oda E, Qawasmi A, Bloch MH (2013) Meta-analysis: melatonin for the treatment of primary sleep disorders. PLOS ONE 8:e63773
Geijlswijk IM, Korzilius HPLM, Smits MG (2010) The use of exogenous melatonin in delayed sleep phase disorder: a meta-analysis. Sleep 33:1605–1614
Kuriyama A, Honda M, Hayashino Y (2014) Ramelteon for the treatment of insomnia in adults: a systematic review and meta-analysis. Sleep Med 15:385–392
Liu J, Wang L‑N (2012) Ramelteon in the treatment of chronic insomnia: systematic review and meta-analysis. Int J Clin Pract 66:867–873
McCleery J, Cohen DA, Sharpley AL (2014) Pharmacotherapies for sleep disturbances in Alzheimer’s disease (review). Cochrane Database Syst Rev. doi:10.1002/14651858.cd009178.pub2
Zhang W, Chen XY, Su SW, Jia QZ, Ding T, Zhu ZN, Zhang T (2015) Exogenous melatonin for sleep disorders in neurodegenerative diseases: a meta-analysis of randomized clinical trials. Neurol Sci 37(1):57–65. doi:10.1007/s10072-015-2357-0
2.7.3. Weitere Therapieverfahren
Chen HY, Shi XY, Ng CS, Chan SM, Yung KK, Zhang QL (2007) Auricular acupuncture treatment for insomnia: a systematic review. J Altern Complement Med 13:669–676
Cheuk DKL, Yeung WF, Chung KF, Wong V (2012) Acupuncture for insomnia (review). Cochrane Database Syst Rev 9. doi:10.1002/14651858.cd005472.pub3
Cooper KL, Relton C (2010) Homeopathy for insomnia: a systematic review of research evidence. Sleep Med Rev 14:329–337
De Niet G, Tiemens B, Lendemeijer B, Hutschemaekers G (2009) Music-assisted relaxation to improve sleep quality: meta-analysis. J Adv Nurs 65:1356–1364
Ernst E (2011) Homeopathy for insomnia and sleeprelated disorders: a systematic review of randomized controlled trials. Focus Altern Complement Ther 16:195–199
Hwang E, Shin S (2015) The effects of aromatherapy on sleep improvement: a systematic literature review and meta-analysis. J Altern Complement Med 21:61–68
Jespersen KV, Koenig J, Jennum P, Vuust P (2015) The Cochrane collaboration: music for insomnia in adults (review). John Wiley & Sons, Chichester
Kanen JW, Nazir R, Sedkys K, Pradhan BK (2015) The effects of mindfulness-based interventions on sleep disturbance: a meta-analysis. Adolesc Psychiatry 5:105–115
Kredlow MA, Capozzoli MC, Hearon BA, Calkins AW, Otto MW (2015) The effects of physical activity on sleep: a meta-analytic review. J Behav Med 38:427–449
Lam T‑H, Chung K‑F, Yeung W‑F, Yu BY-M, Yung K‑P, Ng TH-Y (2015) Hypnotherapy for insomnia: a systematic review and meta-analysis of randomized controlled trials. Complement Ther Med 23:719–732
Lan Y, Tan HT, Wu N, Xing JJ, Wu FS, Zhang LX, Liang FR (2015) Auricular acupuncture with seed or pellet attachments for primary insomnia: a systematic review and meta-analysis. BMC Complement Altern Med 15:103. doi:10.1186/s12906-015-0606-7
Lee J, Han M, Chung Y, Kim J, Choi J (2011) Effects of foot reflexology on fatigue, sleep and pain: a systematic review and meta-analysis. J Korean Acad Nurs 41:821–833
Lillehei AS, Halcon LL (2014) A systematic review of the effect of inhaled essential oils on sleep. J Altern Complement Med 20:441–451
Van Maanen A, Meijer AM, van der Heijden KB, Ooort FJ (2016) The effects of light therapy on sleep problems: a systematic review and meta-analysis. Sleep Med Rev 29:52–62
Wang C‑F, Sun Y‑L, Zang H‑X (2014) Music therapy improves sleep quality in acute and chronic sleep disorders: a meta-analysis of 10 randomized studies. Int J Nurs Stud 51:51–62
Wang F, Lee OE-K, Feng F, Vitiello MV, Wang W, Benson H, Fricchione GL, Denninger JW (2016) The effect of meditative movement on sleep quality: a systematic review. Sleep Med Rev 30:43–52
Wu WW, Kwong E, Lan XY, Jiang XY (2015) The effect of meditative movement intervention on quality of sleep in the elderly: a systematic review and meta-analysis. J Altern Complement Med 21:509–519
Yeung W‑F, Chung K‑F, Poon MM-K, Ho FY-Y, Zhang S‑P, Zhang Z‑J, Ziea ET-C, Wong VT (2012) Acupressure, reflexology, and auricular acupressure for insomnia: a systematic review of randomized controlled trials. Sleep Med 13:971–984
2.7.4. Langzeittherapie von Insomnien mit Hypnotika
Ancoli-Insrael S, Krystal AD, McCall WV, Schaefer K, Wilson A, Rubens RCR, Roth T (2010) A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia. Sleep 33:225–234
Krystal AD, Walsh JK, Laska E, Caron J, Amato DA, Wessel TC, Roth T (2003) Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep 26:793–799
Krystal AD, Erman M, Zammit GK, Soubrane C, Roth R (2008) Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: A 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study. Sleep 31:79–90
Krystal AD, Durrence HH, Scharf M, Jochelson P, Rogowski R, Ludington E, Roth T (2010) Efficacy and safety of doxepin 1 mg and 3 mg in a 12-week sleep laboratory and outpatient trial of elderly subjects with chronic primary insomnia. Sleep 33:1553–1561
Mayer G, Wang-Weigand S, Roth-Schechter B, Lehmann R, Staner C, Partinen M (2009) Efficacy and safety of 6‑month nightly ramelteon administration in adults with chronic primary insomnia. Sleep 32:351–360
Michelson D, Snyder E, Paradis E, Chengan-Liu M, Snavely DB, Hutzelmann J, Walsh JK, Krystal AD, Benca RM, Cohn M, Lines C, Roth T, Herring WJ (2014) Safety and efficacy of suvorexant during 1‑year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial. Lancet Neurol 13:461–471
Perlis ML, McCall WV, Krystal AD, Walsh JK (2004) Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia. J Clin Psychiatry 65:1128–1137
Randall S, Roehrs TA, Roth T (2012) Efficacy of eight months of nightly zolpidem: a prospective placebo-controlled study. Sleep 35:1551–1557
Roehrs TA, Randall S, Harris E, Maan R, Roth T (2011) Twelve months of nightly zolpidem does not lead to dose escalation: a prospective placebo-controlled study. Sleep 34:207–212
Roth T, Walsh JK, Krystal A, Wessel T, Roehrs TA (2005) An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia. Sleep Med 6:487–495
Uchimura N, Kamijo A, Takase T (2012) Effects of eszopiclone on safety, subjective measures of efficacy, and quality of life in elderly and nonelderly Japanese patients with chronic insomnia, both with and without comorbid psychiatric disorders: a 24-week, randomized, double-blind study. Ann Gen Psychiatry 11:15. doi:10.1186/1744-859X-11-15
Walsh JK, Krystal AD, Amato DA, Rubens R, Caron J, Wessel TC, Schaefer K, Roach J, Wallenstein G, Roth T (2007) Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations. Sleep 30:959–968
2.7.5. Risiken und Nebenwirkungen der Insomniebehandlung
Barker MJ, Greenwood KM, Jackson M, Crowe SF (2004) Persistence of cognitive effects after withdrawal from longterm benzodiazepine use: ameta-analysis. Arch Clin Neuropsychol 19:437–454
Dassanayake T, Micie P, Carter G, Jones A (2011) Effects of benzodiazepines, antidepressants, and opoids on driving. A systematic review and meta-analysis of epidemiological and experimental evidence. Drug Saf 34:125–156
Hajak G, Müller WE, Wittchen HU, Pittrow D, Kirch W (2003) Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction 98(10):1371–1378
Hallfors DD, Saxe L (1993) The dependence potential of short half-life benzodiazepines. Am J Public Health 83:1300–1304
Hoffmann F, Pfannkuche M, Glaeske G (2008) Hochverbrauch von Zolpidem und Zopiclon. Nervenarzt 79:67–72
Hoffmann F, Scharffetter W, Glaeske G (2009) Verbrauch von Zolpidem und Zo-piclon auf Privatrezepten zwischen 1993 und 2007. Nervenarzt 80:578–583
Hoffmann F (2013) Benefits and risks of benzodiazepines and Z‑drugs: comparison of perceptions of GPs and community pharmacists in Germany. Ger Med Sci 11:1–7
Joya FL, Kripke DF, Loving RT, Dawson A, Kline LE (2009) Meta-analyses of hypnotics and infections: eszopiclone, ramelteon, zaleplon, and zolpidem. J Clin Sleep Med 5:377–383
Kapil V, Green JL, Le Lait C, Wood M, Dargan PI (2014) Misuse of benzodiazepines and Z‑drugs in the UK. Br J Psychiatry 205:407–408
Kraus L, Pabst A (2010) Epidemiologischer Suchtsurvey. Repräsentativerhebung zum Gebrauch und Missbrauch psychoaktiver Substanzen bei Erwachsenen in Deutschland. Sucht 56:309–384
Kripke DF, Simons RN, Garfinkel L, Hammond EC (1979) Short and long sleep and sleeping pills. Is increased mortality associated? Arch Gen Psychiatry 36:103–116
Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR (2002) Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry 59:131–136
Kripke DF (2009) Do hypnotics cause death and cancer? The burden of proof. Sleep Med 10:275–276
Kripke DF (2011) Is insomnia associated with mortality? Sleep 34:557–558
Kripke DF (2013) Surprising view of insomnia and sleeping pills. Sleep 36:1127–1128
Kyle SD, Morgan K, Spiegelhalder K, Espie CA (2011) No pain, no gain: An exploratory within-subjects mixed-methods evaluation of the patient experience of sleep restriction therapy (SRT) for insomnia. Sleep Med 12:735–747
Kyle SD, Miller CB, Rogers Z, Siriwardena N, MacMahon KM (2014) Sleep restriction therapy for insomnia is associated with reduced objective total sleep time, increased daytime somnolence, and objectively impaired vigilance: Implications for the clinical management of insomnia disorder. Sleep 37:229–237
Palmaro A, Dupouy J, Lapeyre-Mestre M (2015) Benzodiazepines and risk of death: results from two large cohort studies in France and UK. Eur Neuropsychopharmacol 25:1566–1577
Rapoport MJ, Lanctot KL, Streiner DL, Bedard M, Vingilis E, Murray B, Schaffer A, Shulman KL, Herrmann N (2009) Benzodiazepine use and driving: a meta-analysis. J Clin Psychiatry 70:663–673
Soldatos CR, Dikeos DG, Whitehead A (1999) Tolerance and rebound insomnia with rapidly eliminated hypnotics: a meta-analysis of sleep laboratory studies. Int Clin Psychopharmacol 14:287–303
Stranks EK, Crowe SF (2014) The acute cognitive effects of zopiclone, zolpidem, zaleplon, and eszopiclone: a systematic review and meta-analysis. J Clin Exp Neuropsychol 36:691–700
Sun Y, Lin CC, Lu CJ, Hsu CY, Kao CH (2016) Association between zolpidem and suicide: a nationwide population-based case-control study. Mayo Clin Proc 91(3):308–315. doi:10.1016/j.mayocp.2015.10.022
Uhlenhuth EH, Balter MB, Ban TA, Yang K (1999) Benzodiazepine dependence and withdrawal: myths and management. J Clin Psychopharmacol 19(Suppl 2):23S–29S
Verster JC, Veldhuizen DS, Patat A, Olivier B, Volkerts ER (2006) Hypnotics and riving safety: meta-analyses of randomized controlled trials applying the on-the-road driving test. Curr Drug Saf 1:63–71
3. Empfehlungen
Clinical Guidelines Committee of the American College of Physicians (2016) Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. doi:10.7326/M15-2175
Moher et al (1999) Improving the quality of reports of meta-analyses of randomised controlled trials: the quorom statement. Lancet 27:1890–1900
Author information
Authors and Affiliations
Corresponding author
Caption Electronic Supplementary Material
Rights and permissions
About this article
Cite this article
Riemann, D., Baum, E., Cohrs, S. et al. S3-Leitlinie Nicht erholsamer Schlaf/Schlafstörungen. Somnologie 21, 2–44 (2017). https://doi.org/10.1007/s11818-016-0097-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11818-016-0097-x